PlexBio Co., Ltd. (TPEX:6572)
Taiwan · Delayed Price · Currency is TWD 8.08
-0.23 (-2.77%)
At close: Feb 11, 2026
PlexBio Revenue
PlexBio had revenue of 58.28M TWD in the half year ending June 30, 2025, a decrease of -39.81%. This brings the company's revenue in the last twelve months to 153.06M, up 47.69% year-over-year. In the year 2024, PlexBio had annual revenue of 128.06M, down -23.40%.
Revenue (ttm)
153.06M
Revenue Growth
+47.69%
P/S Ratio
5.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
837.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 128.06M | -39.11M | -23.40% |
| Dec 31, 2023 | 167.18M | -24.01M | -12.56% |
| Dec 31, 2022 | 191.19M | 66.25M | 53.02% |
| Dec 31, 2021 | 124.94M | 23.60M | 23.28% |
| Dec 31, 2020 | 101.35M | 30.17M | 42.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| Cowealth Medical Holding | 3.41B |
| AViTA | 896.85M |
| Bioptik Technology Incorporation | 829.18M |
| Health & Life | 441.84M |
| Radiant Innovation | 413.06M |
| Wiltrom | 338.37M |
| S&S Healthcare Holding | 205.64M |